These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11468859)

  • 1. [Economic evaluation of colorectal cancer screening with fecal occult blood detection].
    Maté Jiménez J
    Rev Esp Enferm Dig; 2000 Nov; 92(11):764-5. PubMed ID: 11468859
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic evaluation of colorectal cancer screening with fecal occult blood detection.
    Tárraga López PJ; Marín Nieto E; Celada Rodríguez A; García Molinero MJ; García Olmo D; Solera Albero J
    Rev Esp Enferm Dig; 2000 May; 92(5):334-48. PubMed ID: 10927933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
    Yamamoto M; Nakama H
    Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effective screening strategies for colorectal cancer.
    Whynes DK; Walker AR; Hardcastle JD
    J Public Health Med; 1992 Mar; 14(1):43-9. PubMed ID: 1599742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 6. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
    Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
    J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of colorectal carcinoma. An update].
    Schneider AR; Caspary WF
    Radiologe; 2003 Feb; 43(2):105-12. PubMed ID: 12624667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of fecal occult blood and colorectal cancer].
    Herrerías Gutiérrez JM; Caunedo Alvarez JM; Herrerías Esteban JM
    Rev Esp Enferm Dig; 1999 May; 91(5):331-4. PubMed ID: 10362874
    [No Abstract]   [Full Text] [Related]  

  • 13. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer.
    Allison JE
    N Engl J Med; 1993 Oct; 329(18):1352; author reply 1353-4. PubMed ID: 8413420
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for colorectal cancer.
    Budenholzer B
    CMAJ; 2001 Apr; 164(7):965-6; author reply 967-8. PubMed ID: 11314442
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for colorectal cancer.
    Brock G; Gurekas V
    CMAJ; 2001 Apr; 164(7):966; author reply 967-8. PubMed ID: 11314445
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical fecal occult blood tests for colorectal cancer screening.
    Allison JE
    Am J Med; 2004 Apr; 116(7):498; author reply 498-9. PubMed ID: 15047043
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.